Subscribe
Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Authors

Podcasts

About
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals More

Online First

October 14, 2019

Correspondence
Incidence of inflammatory bowel disease in patients with ankylosing spondylitis
Free

Shih-Wei Lai, Yu-Hung Kuo, Kuan-Fu Liao

doi: 10.1136/annrheumdis-2019-216362
Correspondence
Bone health in patients with systemic lupus erythematosus
Free

Shih-Wei Lai, Yu-Hung Kuo, Kuan-Fu Liao

doi: 10.1136/annrheumdis-2019-216417
Correspondence response
On the therapeutic scope of low-dose IL-2. Response to: ‘Circulating regulatory T cells were absolutelydecreased in dermatomyositis/polymyositispatients and restored by low-dose IL-2’ by Zhang et al
Free

David Klatzmann

doi: 10.1136/annrheumdis-2019-216267

October 11, 2019

Correspondence response
Response to: ‘Response to: “Influence of changes in cholesterol levels and disease activity on the 10-year cardiovascular risk estimated with different algorithms in rheumatoid arthritis patients” by Fornaro et al’ by Agca et al
Free

Marco Fornaro, Fabio Cacciapaglia, Vincenzo Venerito, Giuseppe Lopalco, Florenzo Iannone

doi: 10.1136/annrheumdis-2019-216407
Correspondence response
Importance of high-quality ANA testing for SLE classification. Response to: ‘Role of ANA testing in the classification of patients with systemic lupus erythematosus’ by Pisetsky et al
Free

Martin Aringer, Karen H Costenbader, Thomas Dörner, Sindhu R Johnson

doi: 10.1136/annrheumdis-2019-216337
Correspondence
Overlap of systemic lupus erythematosus and myositis is rare in anti-Ku antibody-positive patients
Free

Mariko Ogawa-Momohara, Yoshinao Muro, Masashi Akiyama

doi: 10.1136/annrheumdis-2019-216375

October 10, 2019

Correspondence response
Response to: ‘Medications associated with fracture risk in patients with rheumatoid arthritis’ by Chen et al
Free

Gulsen Ozen, Kaleb Michaud

doi: 10.1136/annrheumdis-2019-216293
Correspondence
Association of anti-Ro52 autoantibodies with interstitial lung disease in connective tissue diseases
Free

Si Wu, Xiaojun Tang, Liping Wu, Liang-jing Lu, Xuebing Feng

doi: 10.1136/annrheumdis-2019-216372
Correspondence response
Could we use salivary gland ultrasonography as a prognostic marker in Sjogren’s syndrome? Response to: ‘Ultrasonographic damages of major salivary glands are associated with cryoglobulinemic vasculitis and lymphoma in primary Sjogren’s syndrome: are the ultrasonographic features of the salivary glands new prognostic markers in Sjogren's syndrome?’ by Coiffier et al
Free

Sandrine Jousse-Joulin, Maria Antonietta D'Agostino, Alojzija Hočevar, Esperanza Naredo, Lene Terslev, Sarah Ohrndorf, Annamaria Iagnocco, Wolfgang A Schmidt, Stephanie Finzel, Zarrin Alavi, George A W Bruyn on behalf the Salivary Gland subgroup of the OMERACT US working group

doi: 10.1136/annrheumdis-2019-216327
Correspondence response
Response to ‘Titre-specific positive predictive value of anti-nuclear antibody patterns’ by Vulsteke et al
Free

Jan Damoiseaux, Luís Eduardo Coelho Andrade, Marvin J Fritzler, Manfred Herold, Maria Infantino, Carlos von Muhlen

doi: 10.1136/annrheumdis-2019-216266

September 18, 2019

Correspondence response
Response to: ‘Diabetes mellitus in ankylosing spondylitis’ by Liao et al
Free

Sylvain Mathieu, Martin Soubrier

doi: 10.1136/annrheumdis-2019-216249
Correspondence response
Response to: ‘New 2019 SLE EULAR/ACR classification criteria are valuable for distinguishing patients with SLE from patients with pSS’ by Assan et al
Free

Martin Aringer, Karen Costenbader, Thomas Dörner, Sindhu R Johnson

doi: 10.1136/annrheumdis-2019-216250

September 17, 2019

Correspondence
Medications associated with fracture risk in patients with rheumatoid arthritis
Free

Yi-Sheng Liou, Tsung-Kun Lin, Hung-Yi Chen, Gwo-Ping Jong

doi: 10.1136/annrheumdis-2019-216262

September 16, 2019

Correspondence
Do the 2019 EULAR/ACR SLE classification criteria close the door on certain groups of SLE patients?
Free

Huihui Chi, Jialin Teng, Zhihong Wang, Chengde Yang, Yutong Su

doi: 10.1136/annrheumdis-2019-216253

September 09, 2019

Correspondence
New 2019 SLE EULAR/ACR classification criteria are valuable for distinguishing patients with SLE from patients with pSS
Free

Florence Assan, Raphaele Seror, Xavier Mariette, Gaetane Nocturne

doi: 10.1136/annrheumdis-2019-216222

September 06, 2019

Correspondence response
Response to: ‘Novel NLRP12 variant presenting with familial cold autoimmunity syndrome phenotype’ by Gupta et al
Free

Charlotte Eijkelboom, Nienke M Ter Haar, Joost Frenkel, Marco Gattorno

doi: 10.1136/annrheumdis-2019-216184
Correspondence
Correspondence to ‘Standardisation of myositis-specific antibodies: where are we today?’ by Mahler et al
Free

Maria Infantino, Mariangela Manfredi, Nicola Bizzaro

doi: 10.1136/annrheumdis-2019-216217
Correspondence
Diabetes mellitus in ankylosing spondylitis
Free

Kuan-Fu Liao, Yu-Hung Kuo, Shih-Wei Lai

doi: 10.1136/annrheumdis-2019-216221
Correspondence
‘DESIRABLE’ or not?
Free

Nupoor Acharya, Arghya Chattopadhyay, Varun Dhir

doi: 10.1136/annrheumdis-2019-216236

August 31, 2019

Correspondence response
Response to: ‘Chronic hydroxychloroquine exposure and the risk of Alzheimer’s disease’ by Lai et al
Free

Laurence Fardet, Irene Petersen, Irwin Nazareth

doi: 10.1136/annrheumdis-2019-216182

August 27, 2019

Correspondence
What is the starting dose of steroid prescribed by rheumatologist in the management of polymyalgia rheumatica?
Free

Jean Jacques Dubost, Bruno Pereira, Angelique Fan, Martin Soubrier

doi: 10.1136/annrheumdis-2019-216050

August 26, 2019

Correspondence response
Response to: “Influence of changes in cholesterol levels and disease activity on the 10-year cardiovascular risk estimated with different algorithms in rheumatoid arthritis patients” by Fornaro et al
Free

Rabia Agca, Sjoerd C Heslinga, S Rollefstad, S Heslinga, Anna Södergren, AG Semb, George D Kitas, Naveed Sattar, Michael T Nurmohamed on behalf of The EULAR task force “EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update”

doi: 10.1136/annrheumdis-2019-215748

August 24, 2019

Correspondence
Novel NLRP12 variant presenting with familial cold autoimmunity syndrome phenotype
Free

Latika Gupta, Sakir Ahmed, Bharati Singh, Satya Prakash, Shubha Phadke, Amita Aggarwal

doi: 10.1136/annrheumdis-2019-216158

August 21, 2019

Correspondence
Chronic hydroxychloroquine exposure and the risk of Alzheimer’s disease
Free

Shih-Wei Lai, Yu-Hung Kuo, Kuan-Fu Liao

doi: 10.1136/annrheumdis-2019-216173

August 20, 2019

Correspondence response
Response to ‘Steroid sparing effect: an essential element in assessing therapeutic efficacy in SLE: response to ‘Time to change the primary outcome of lupus trials’ by Houssiau’ by Oon et al
Free

Frederic A Houssiau

doi: 10.1136/annrheumdis-2019-216160

August 17, 2019

Correspondence
Risk of gout flares after vaccination
Free

Shih-Wei Lai, Yu-Hung Kuo, Kuan-Fu Liao

doi: 10.1136/annrheumdis-2019-216146
Correspondence response
Welcome to EULAR’s guidelines for the use of big data techniques in rheumatic and musculoskeletal diseases. Response to: ‘On using machine learning algorithms to define clinically meaningful patient subgroups’ by Knevel and Huizinga
Free

Alain Meyer, Lionel Spielmann, François Séverac

doi: 10.1136/annrheumdis-2019-215989

August 16, 2019

Correspondence
Steroid sparing effect: an essential element in assessing therapeutic efficacy in SLE: response to ‘Time to change the primary outcome of lupus trials’ by Houssiau
Free

Shereen Oon, Molla Huq, Mandana Nikpour

doi: 10.1136/annrheumdis-2019-216113
Correspondence
Ultrasonographic damages of major salivary glands are associated with cryoglobulinemic vasculitis and lymphoma in primary Sjogren’s syndrome: are the ultrasonographic features of the salivary glands new prognostic markers in Sjogren's syndrome?
Free

Guillaume Coiffier, Amélie Martel, Jean-David Albert, Alain Lescoat, Aurore Bleuzen, Aleth Perdriger, Michel De Bandt, François Maillot

doi: 10.1136/annrheumdis-2019-216122
Correspondence response
Fostering the application of the MS score in systemic juvenile idiopathic arthritis. Response to: ‘MS score in systemic juvenile idiopathic arthritis: suitable for routine use?’ by Chi et al
Free

Francesca Minoia, Angelo Ravelli

doi: 10.1136/annrheumdis-2019-216067

August 13, 2019

Correspondence response
Response to: “How to communicate in science” by Klareskog et al
Free

René Toes, David S Pisetsky

doi: 10.1136/annrheumdis-2019-216045
Correspondence
How to communicate in science
Free

Lars Klareskog, Anca Irinel Catrina, Camilla Svensson, Vivianne Malmstrom

doi: 10.1136/annrheumdis-2019-216016

August 12, 2019

Correspondence response
Response to: ‘Association between proton pump inhibitors therapy and fracture risk in patients with rheumatoid arthritis’ by Lai et al
Free

Gulsen Ozen, Kaleb Michaud

doi: 10.1136/annrheumdis-2019-215992

August 07, 2019

Correspondence response
Response to: ‘Performance of the systemic lupus erythematosus disease activity score (SLE-DAS) in a Latin American population’, by Rodríguez-González et al
Free

Diogo Jesus, Ana Matos, Carla Henriques, Margherita Zen, Andrea Doria, Luís Sousa Inês

doi: 10.1136/annrheumdis-2019-216110
Correspondence response
Response to: ‘Ultrasonographic salivary gland evaluation in systemic sclerosis: is sicca syndrome secondary to an authentic overlap syndrome or another specific fibrotic manifestation of the disease?’ by Coiffier et al
Free

Marion Couderc, Jean-Jacques Dubost

doi: 10.1136/annrheumdis-2019-215991

August 03, 2019

Correspondence
Standardisation of myositis-specific antibodies: where are we today?
Free

Michael Mahler, Jean-Baptiste Vulsteke, Xavier Bossuyt, Ellen De Langhe, Minoru Satoh

doi: 10.1136/annrheumdis-2019-216003
Correspondence
Anti-Ku syndrome with elevated CK: association with myocardial involvement in systemic sclerosis
Free

Corrado Campochiaro, Giacomo De Luca, Maria De Santis

doi: 10.1136/annrheumdis-2019-216070

August 02, 2019

Correspondence
MS score in systemic juvenile idiopathic arthritis: suitable for routine use?
Free

Huihui Chi, Zhihong Wang, Chengde Yang, Yutong Su

doi: 10.1136/annrheumdis-2019-216041

July 31, 2019

Correspondence response
Response to: ‘Response to: ‘Alcohol is not the missing link between Porphyromonas gingivalis related periodontitis and radiologic progression in early Rheumatoid arthritis’ by Hillion et al’ by Marotte and Paul
Free

Alexandre Bellier, Xavier Romand, Athan Baillet

doi: 10.1136/annrheumdis-2019-215962

July 30, 2019

Correspondence response
Response to: ‘Bone health, an often forgotten comorbidity in systemic lupus erythematosus: a comment on the new recommendations’ by Orsolini et al
Free

Antonis Fanouriakis, George Bertsias, Dimitrios T Boumpas

doi: 10.1136/annrheumdis-2019-215944
Correspondence
Augmented versus artificial intelligence for stratification of patients with myositis
Free

Michael Mahler, Brenden Rossin, Olga Kubassova

doi: 10.1136/annrheumdis-2019-216000
Correspondence response
Artificial intelligence should always be guided by human intelligence. Response to ‘Augmented vs. artificial intelligence for stratification of patients with myositis’ by Mahler et al
Free

Alain Meyer, Lionel Spielmann, François Séverac

doi: 10.1136/annrheumdis-2019-216014

July 29, 2019

Correspondence
Performance of the Systemic lupus erythematosus disease activity score (SLE-DAS) in a Latin American population.
Free

Melissa G Rodríguez-González, Grissell A Valero-Gaona, Tania Vargas-Aguirre, Luis M Amezcua Guerra

doi: 10.1136/annrheumdis-2019-216028

July 22, 2019

Correspondence response
Treat to target in PsA should focus on clinical measures. Response to: ‘DAPSA versus cDAPSA: do we need use CRP?’ by Gonçalves et al
Free

Leonieke J J van Mens, Marleen G H van de Sande, Arno W R van Kuijk, Dominique Baeten, Laura C Coates

doi: 10.1136/annrheumdis-2019-215990
Correspondence
DAPSA versus cDAPSA: Do we need to use CRP?
Free

Rafaela Silva Guimarães Gonçalves, Lays Miranda de Almeida Martins, Henrique de Ataide Mariz, Andrea Tavares Dantas, Angela Luzia Branco Pinto Duarte

doi: 10.1136/annrheumdis-2019-215960

July 20, 2019

Correspondence response
Response to: ‘On using machine learning algorithms to define clinically meaningful patient subgroups’ by Pinal-Fernandez and Mammen
Free

Olivier Benveniste, Yves Allenbach, Benjamin Granger

doi: 10.1136/annrheumdis-2019-216007

Log in using your username and password

Main menu

Log in using your username and password

You are here

Online First

October 14, 2019

October 11, 2019

October 10, 2019

October 04, 2019

October 03, 2019

September 20, 2019

September 18, 2019

September 17, 2019

September 16, 2019

September 09, 2019

September 06, 2019

August 31, 2019

August 27, 2019

August 26, 2019

August 24, 2019

August 21, 2019

August 20, 2019

August 17, 2019

August 16, 2019

August 13, 2019

August 12, 2019

August 07, 2019

August 03, 2019

August 02, 2019

July 31, 2019

July 30, 2019

July 29, 2019

July 22, 2019

July 20, 2019

Pages